Company / CapEx per Share
Quest Diagnostics CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$4.66
FY2025
5-year range
$2.94 / $4.66
FY2021-FY2025
Trend
+29.5%
vs FY2024
Sector context
#12 of 148
Health Care
What the data says
Among 148 Health Care companies, Quest Diagnostics is in the top 8% for capex per share. CapEx per Share has increased for 4 consecutive years, from $2.94 in FY2021 to $4.66 in FY2025.
Based on SEC 10-K filings.
4.66 in FY2025 with a 5-year CAGR of +9.2%. Top quartile in the Health Care sector.
Improved from $3.15 to $4.66 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +14.9%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 148This company $4.66 Sector average $1.67
▼
+178.8% above sector average
Key checks
Key Insights
- Quest Diagnostics's capex per share has grown for 4 consecutive years.
- In FY2025, capex per share increased 29.5% year-over-year.
- Ranks #12 out of 148 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.66 | +29.5% |
| FY2024 | $3.60 | +14.4% |
| FY2023 | $3.15 | +2.4% |
| FY2022 | $3.07 | +4.5% |
| FY2021 | $2.94 | -2.2% |
| FY2020 | $3.01 | +67.1% |
| FY2019 | $1.80 | -12.8% |
| FY2018 | $2.06 | +13.8% |
| FY2017 | $1.81 | -14.6% |
| FY2016 | $2.12 | +40.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026